Works matching IS 15330028 AND DT 2023 AND VI 22 AND IP 2
Results: 11
SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS).
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 231, doi. 10.1016/j.clcc.2023.02.005
- By:
- Publication type:
- Article
Patient-reported Bowel Function and Bowel-related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical Resection.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 211, doi. 10.1016/j.clcc.2023.02.003
- By:
- Publication type:
- Article
A Case of Heavily Pretreated HER2+ Colorectal Liver Metastases Responsive to Hepatic Arterial Infusion Chemotherapy.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 245, doi. 10.1016/j.clcc.2023.02.006
- By:
- Publication type:
- Article
Incidence of Disease Recurrence in Patients With Colon and Upper Rectum Adenocarcinoma Stage II and III Receiving Adjuvant Capecitabine Monotherapy: Do Number of Chemotherapy Cycles and Relative Dose Intensity of the Drug Play a Role?
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 238, doi. 10.1016/j.clcc.2023.02.007
- By:
- Publication type:
- Article
Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 222, doi. 10.1016/j.clcc.2023.02.004
- By:
- Publication type:
- Article
Improving Outcome of Selected Patients With Non-Resectable Hepatic Metastases From Colorectal Cancer with Liver Transplantation: A Prospective Parallel Trial (COLT trial).
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 250, doi. 10.1016/j.clcc.2023.01.003
- By:
- Publication type:
- Article
Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochernical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 199, doi. 10.1016/j.clcc.2023.02.001
- By:
- Publication type:
- Article
Prognostic Value of Body Mass Index in Stage II/III Colon Cancer: Posthoc Analysis From the TOSCA Trial.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 190, doi. 10.1016/j.clcc.2023.01.004
- By:
- Publication type:
- Article
Colorectal Cancer Screening Disparities Among Race: A Zip Code Level Analysis.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 183, doi. 10.1016/j.clcc.2023.01.001
- By:
- Publication type:
- Article
The Role of Immunotherapy in Esophageal and Gastric Cancer.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 175, doi. 10.1016/j.clcc.2023.03.001
- By:
- Publication type:
- Article
Patterns of Care for Patients With Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy at Predominately Academic Centers between 2016-2020: An NCDB Analysis.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 167, doi. 10.1016/j.clcc.2023.01.005
- By:
- Publication type:
- Article